Insider trades › Amgen · Amgen company page
Amgen insider trading
Transactions in AMGN stock reported by Amgen executives, directors and large holders on SEC Form 4 over the last 120 days. Last update 2026-10-14.
$4.1Mopen-market sales (10,112 shares, 3 insiders)
$0open-market purchases (0 shares, 0 insiders)
7Form 4 filings
Insiders
Derek Miller SVP, Human Resources Sold $1.6M Rachna Khosla SVP, Business Development Sold $1.3M Nancy A. Grygiel SVP & CCO Sold $1.2M Matthew C. Busch VP, Finance & CAO 1 other transaction Omar Ishrak Director 1 other transaction Charles M Holley Director 1 other transaction Michael V Drake Director 1 other transaction
All transactions
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Rachna Khosla SVP, Business Development | Option or RSU exercise | 1,252 | $162.60 | — | Form 4 ↗ |
| Aug 13, 2026 | Rachna Khosla SVP, Business Development | Open-market sale | 1,252 | $416.43 | $521K | Form 4 ↗ |
| Aug 11, 2026 | Rachna Khosla SVP, Business Development | Open-market sale | 2,000 | $412.57 | $825K | Form 4 ↗ |
| Aug 7, 2026 | Matthew C. Busch VP, Finance & CAO | Grant or award | 730 | — | — | Form 4 ↗ |
| Aug 7, 2026 | Omar Ishrak Director | Grant or award | 85 | — | — | Form 4 ↗ |
| Aug 7, 2026 | Charles M Holley Director | Grant or award | 103 | — | — | Form 4 ↗ |
| Aug 7, 2026 | Michael V Drake Director | Grant or award | 64 | — | — | Form 4 ↗ |
| Aug 6, 2026 | Derek Miller SVP, Human Resources | Option or RSU exercise | 2,069 | $162.60 | — | Form 4 ↗ |
| Aug 6, 2026 | Derek Miller SVP, Human Resources | Open-market sale | 2,069 | $402.54 | $833K | Form 4 ↗ |
| Aug 6, 2026 | Derek Miller SVP, Human Resources | Option or RSU exercise | 1,821 | $177.46 | — | Form 4 ↗ |
| Aug 6, 2026 | Derek Miller SVP, Human Resources | Open-market sale | 1,821 | $402.54 | $733K | Form 4 ↗ |
| Aug 6, 2026 | Nancy A. Grygiel SVP & CCO | Option or RSU exercise | 1,970 | $177.46 | — | Form 4 ↗ |
| Aug 6, 2026 | Nancy A. Grygiel SVP & CCO | Open-market sale | 1,970 | $402.16 | $792K | Form 4 ↗ |
| Aug 6, 2026 | Nancy A. Grygiel SVP & CCO | Option or RSU exercise | 1,000 | $177.31 | — | Form 4 ↗ |
| Aug 6, 2026 | Nancy A. Grygiel SVP & CCO | Open-market sale | 1,000 | $402.16 | $402K | Form 4 ↗ |
Source: SEC EDGAR, Amgen Form 4 filings. Values are shares × reported price for open-market trades. Insider trades are reported facts, not recommendations. Not investment advice. See the tracker for how to read the codes.